Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein modifications.
AstronauTx is a biotechnology company that develops small-molecule therapeutics for neurological diseases by targeting sleep architecture.
Cerecor discovers, develops and commercializes neuroscience drugs.
Orna Therapeutics is a biotechnology company that specializes in fully engineered circular RNA therapeutics to treat various diseases.
K2 Therapeutics creates advanced antibody-based therapies focused on difficult multi-pass membrane targets to address unmet disease needs.
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
āshibio is a privately held biotechnology business exploring innovative therapies to treat bone and connective tissue ailments.
ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease.
ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.
Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.
TriNetX is a health research network that connects drug discovery and development from pharmaceutical companies.
Crossbow Therapeutics is a biotech company that develops targeted therapies to address cancer antigens.
NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.
Reunion Neuroscience is a clinical-stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions.
Firefly Bio specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders.
Early stage biotechnology company
Arialys Therapeutics is a pre-clinical stage company that develops auto-antibody focusing on neuroscience.
SiO2 Materials Science is a plastic container designing company.
CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity.
iOmx Therapeutics focuses on the development of cancer immunotherapy treatments.
Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.
Werewolf Therapeutics operates as an oncology biotherapeutics company.
MPM Capital has invested in 50 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
MPM Capital's top investment sectors include Biotechnology, Therapeutics, Medical, Health Care, Pharmaceutical. The firm invests across 18 different industry categories.
Among tracked funding rounds, ReNAgade Therapeutics received $300.0M in a Series A round. MPM Capital's total known invested capital is $3.8B.
MPM Capital's average investment size is $101.2M across its portfolio of 50 companies.
Recent MPM Capital portfolio additions include Photys Therapeutics, AstronauTx, Cerecor, Orna Therapeutics, K2 Therapeutics. These companies were founded in 2020 or later.